| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Amgen Center, Thousand Oaks, California 91320-1789 [C. L. F., J. V. B., K. L. R., J. N. C., C. R. D., K. L. W., S. Y., D. C. H., B. W., C. O. S., A. M. H., Z-N. L., S. L. A., G. F. P., A. T., T. R. U., D. L. L.], and Christine CRC Research Centre, Patterson Institute for Cancer Research, Manchester M20 9BX, United Kingdom [C. S. P.]
Keratinocyte growth factor (KGF) stimulates the proliferation and differentiation of epithelial cells including those of the gastrointestinal tract. Although chemotherapeutics and radiation exposure kill rapidly proliferating tumor cells, rapidly dividing normal cells of the host's gastrointestinal tract are also frequently damaged, leading to the clinical condition broadly termed "mucositis." In this report, recombinant human KGF used as a pretreatment in several mouse models of chemotherapy and/or radiation-induced gastrointestinal injury significantly improved mouse survival. Using multiple-dose 5-fluorouracil, methotrexate, and radiation in combination and total body radiation alone models, KGF increased survival by 55% or greater. In the models that used chemotherapy with or without radiation, KGF significantly ameliorated weight loss after injury and accelerated weight gain during recovery. The basis of these systemic benefits appears to be due in part to the trophic effects of the growth factor on the intestinal epithelium because KGF pretreatment caused an increase in measures of mucosal thickness (villus height and crypt depth) that persisted during the course of 5-fluorouracil chemotherapy. Treatment with KGF also afforded a 3.5-fold improvement in crypt survival in the small intestine, suggesting that KGF also has a direct effect on the crypt stem cells. These data indicate that KGF may be therapeutically useful to lessen the intestinal side effects of current cancer therapy regimens.
1 The work of C. S. P. was funded by the Cancer Research Campaign.
2 To whom requests for reprints should be addressed, at Amgen, Inc., 1840 DeHavilland Drive, Thousand Oaks, CA 91320-1789.
3 Present address: Prizm Pharmaceuticals, San Diego, CA 92121.
Received 7/29/97. Accepted 12/31/97.
This article has been cited by other articles:
![]() |
C. Zheng, A. P. Cotrim, A. N. Sunshine, T. Sugito, L. Liu, A. Sowers, J. B. Mitchell, and B. J. Baum Prevention of Radiation-Induced Oral Mucositis after Adenoviral Vector-Mediated Transfer of the Keratinocyte Growth Factor cDNA to Mouse Submandibular Glands Clin. Cancer Res., July 15, 2009; 15(14): 4641 - 4648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Stringer, R. J. Gibson, R. M. Logan, J. M. Bowen, A. S. J. Yeoh, J. Hamilton, and D. M. K. Keefe Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis Experimental Biology and Medicine, April 1, 2009; 234(4): 430 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhao, K.-A. Kim, J. De Vera, S. Palencia, M. Wagle, and A. Abo R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/{beta}-catenin pathway PNAS, February 17, 2009; 106(7): 2331 - 2336. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. King, E. Knopp, A. Galan, G. Nuovo, R. Tigelaar, and J. McNiff Palifermin-Associated Papular Eruption Arch Dermatol, February 1, 2009; 145(2): 179 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Hensley, K. L. Hagerty, T. Kewalramani, D. M. Green, N. J. Meropol, T. H. Wasserman, G. I. Cohen, B. Emami, W. J. Gradishar, R. B. Mitchell, et al. American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants J. Clin. Oncol., January 1, 2009; 27(1): 127 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Brake, C. Starnes, J. Lu, D. Chen, S. Yang, R. Radinsky, and L. Borges Effects of Palifermin on Antitumor Activity of Chemotherapeutic and Biological Agents in Human Head and Neck and Colorectal Carcinoma Xenograft Models Mol. Cancer Res., August 1, 2008; 6(8): 1337 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koria and S. T. Andreadis KGF promotes integrin {alpha}5 expression through CCAAT/enhancer-binding protein-beta Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1020 - C1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Gomperts, J. A. Belperio, M. C. Fishbein, M. P. Keane, M. D. Burdick, and R. M. Strieter Keratinocyte Growth Factor Improves Repair in the Injured Tracheal Epithelium Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 48 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seggewiss, K. Lore, F. J. Guenaga, S. Pittaluga, J. Mattapallil, C. K. Chow, R. A. Koup, K. Camphausen, M. C. Nason, M. Meier-Schellersheim, et al. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood, July 1, 2007; 110(1): 441 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Blijlevens and S Sonis Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis Ann. Onc., May 1, 2007; 18(5): 817 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Min, A. Panoskaltsis-Mortari, M. Kuro-o, G. A. Hollander, B. R. Blazar, and K. I. Weinberg Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging Blood, March 15, 2007; 109(6): 2529 - 2537. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Braun, M. Krampert, E. Bodo, A. Kumin, C. Born-Berclaz, R. Paus, and S. Werner Keratinocyte growth factor protects epidermis and hair follicles from cell death induced by UV irradiation, chemotherapeutic or cytotoxic agents J. Cell Sci., December 1, 2006; 119(23): 4841 - 4849. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Stiff, C. Emmanouilides, W. I. Bensinger, T. Gentile, B. Blazar, T. C. Shea, J. Lu, J. Isitt, A. Cesano, and R. Spielberger Palifermin Reduces Patient-Reported Mouth and Throat Soreness and Improves Patient Functioning in the Hematopoietic Stem-Cell Transplantation Setting J. Clin. Oncol., November 20, 2006; 24(33): 5186 - 5193. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Rosen, E. Abdi, I. D. Davis, J. Gutheil, F. M. Schnell, J. Zalcberg, A. Cesano, U. Gayko, M.-G. Chen, and S. Clarke Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy J. Clin. Oncol., November 20, 2006; 24(33): 5194 - 5200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Blazar, D. J. Weisdorf, T. DeFor, A. Goldman, T. Braun, S. Silver, and J. L. M. Ferrara Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) Blood, November 1, 2006; 108(9): 3216 - 3222. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Finch and J. S. Rubin Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst, June 21, 2006; 98(12): 812 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Geer, D. D. Swartz, and S. T. Andreadis Biomimetic Delivery of Keratinocyte Growth Factor upon Cellular Demand for Accelerated Wound Healing in Vitro and in Vivo Am. J. Pathol., December 1, 2005; 167(6): 1575 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L Radtke and J. M Kolesar Palifermin (KepivanceTM) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support Journal of Oncology Pharmacy Practice, September 1, 2005; 11(3): 121 - 125. [Abstract] [PDF] |
||||
![]() |
K.-A. Kim, M. Kakitani, J. Zhao, T. Oshima, T. Tang, M. Binnerts, Y. Liu, B. Boyle, E. Park, P. Emtage, et al. Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium Science, August 19, 2005; 309(5738): 1256 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vidrich, J. M. Buzan, S. Barnes, B. K. Reuter, K. Skaar, C. Ilo, F. Cominelli, T. Pizarro, and S. M. Cohn Altered Epithelial Cell Lineage Allocation and Global Expansion of the Crypt Epithelial Stem Cell Population Are Associated with Ileitis in SAMP1/YitFc Mice Am. J. Pathol., April 1, 2005; 166(4): 1055 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spielberger, P. Stiff, W. Bensinger, T. Gentile, D. Weisdorf, T. Kewalramani, T. Shea, S. Yanovich, K. Hansen, S. Noga, et al. Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers N. Engl. J. Med., December 16, 2004; 351(25): 2590 - 2598. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Garfunkel Oral Mucositis -- The Search for a Solution N. Engl. J. Med., December 16, 2004; 351(25): 2649 - 2651. [Full Text] [PDF] |
||||
![]() |
J. Zhao, L. Huang, N. Belmar, R. Buelow, and T. Fong Oral RDP58 Allows CPT-11 Dose Intensification for Enhanced Tumor Response by Decreasing Gastrointestinal Toxicity Clin. Cancer Res., April 15, 2004; 10(8): 2851 - 2859. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, P. A. Antony, B. E. Wildhaber, and D. H. Teitelbaum Intestinal Intraepithelial Lymphocyte {gamma}{delta}-T Cell-Derived Keratinocyte Growth Factor Modulates Epithelial Growth in the Mouse J. Immunol., April 1, 2004; 172(7): 4151 - 4158. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Egan, L. Eckmann, F. R. Greten, S. Chae, Z.-W. Li, G. M. Myhre, S. Robine, M. Karin, and M. F. Kagnoff I{kappa}B-kinase{beta}-dependent NF-{kappa}B activation provides radioprotection to the intestinal epithelium PNAS, February 24, 2004; 101(8): 2452 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. O. Morvan, B. Baroukh, D. Ledoux, J.-P. Caruelle, D. Barritault, G. Godeau, and J.-L. Saffar An Engineered Biopolymer Prevents Mucositis Induced by 5-Fluorouracil in Hamsters Am. J. Pathol., February 1, 2004; 164(2): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Alvarez, E. G. Fey, P. Valax, Z. Yim, J. D. Peterson, M. Mesri, M. Jeffers, M. Dindinger, N. Twomlow, A. Ghatpande, et al. Preclinical Characterization of CG53135 (FGF-20) in Radiation and Concomitant Chemotherapy/Radiation-induced Oral Mucositis Clin. Cancer Res., August 1, 2003; 9(9): 3454 - 3461. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Meropol, R. A. Somer, J. Gutheil, R. J. Pelley, M. R. Modiano, E. K. Rowinsky, M. L. Rothenberg, S. W. Redding, C. M. Serdar, B. Yao, et al. Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant J. Clin. Oncol., April 15, 2003; 21(8): 1452 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fernandez-Estivariz, L. H. Gu, L. Gu, C. R. Jonas, T. M. Wallace, R. R. Pascal, K. L. Devaney, C. L. Farrell, D. P. Jones, D. K. Podolsky, et al. Trefoil peptide expression and goblet cell number in rat intestine: effects of KGF and fasting-refeeding Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R564 - R573. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dainiak, J. K. Waselenko, J. O. Armitage, T. J. MacVittie, and A. M. Farese The Hematologist and Radiation Casualties Hematology, January 1, 2003; 2003(1): 473 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruehl, R. Somasundaram, I. Schoenfelder, R. W. Farndale, C. G. Knight, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan The Epithelial Mitogen Keratinocyte Growth Factor Binds to Collagens via the Consensus Sequence Glycine-Proline-Hydroxyproline J. Biol. Chem., July 19, 2002; 277(30): 26872 - 26878. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rossi, B. R. Blazar, C. L. Farrell, D. M. Danilenko, D. L. Lacey, K. I. Weinberg, W. Krenger, and G. A. Hollander Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease Blood, June 28, 2002; 100(2): 682 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Min, P. A. Taylor, A. Panoskaltsis-Mortari, B. Chung, D. M. Danilenko, C. Farrell, D. L. Lacey, B. R. Blazar, and K. I. Weinberg Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation Blood, May 29, 2002; 99(12): 4592 - 4600. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Byrne, C. L. Farrell, R. Aranda, K. L. Rex, S. Scully, H. L. Brown, S. A. Flores, L. H. Gu, D. M. Danilenko, D. L. Lacey, et al. rHuKGF ameliorates symptoms in DSS and CD4+CD45RBHi T cell transfer mouse models of inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G690 - G701. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Booth and C. S. Potten Protection Against Mucosal Injury By Growth Factors and Cytokines J Natl Cancer Inst Monographs, October 1, 2001; 2001(29): 16 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bjerknes and H. Cheng Modulation of specific intestinal epithelial progenitors by enteric neurons PNAS, September 19, 2001; (2001) 211278098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Potten, J. A. O'Shea, C. L. Farrell, K. Rex, and C. Booth The Effects of Repeated Doses of Keratinocyte Growth Factor on Cell Proliferation in the Cellular Hierarchy of the Crypts of the Murine Small Intestine Cell Growth Differ., May 1, 2001; 12(5): 265 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Welniak, A. R. Khaled, M. R. Anver, K. L. Komschlies, R. H. Wiltrout, S. Durum, F. R. Ruscetti, B. R. Blazar, and W. J. Murphy Gastrointestinal Cells of IL-7 Receptor Null Mice Exhibit Increased Sensitivity to Irradiation J. Immunol., March 1, 2001; 166(5): 2923 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Boushey, B. Yusta, and D. J. Drucker Glucagon-like Peptide (GLP)-2 Reduces Chemotherapy-associated Mortality and Enhances Cell Survival in Cells Expressing a Transfected GLP-2 Receptor Cancer Res., January 1, 2001; 61(2): 687 - 693. [Abstract] [Full Text] |
||||
![]() |
A. Panoskaltsis-Mortari, P. A. Taylor, J. S. Rubin, A. Uren, L. A. Welniak, W. J. Murphy, C. L. Farrell, D. L. Lacey, and B. R. Blazar Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury Blood, December 15, 2000; 96(13): 4350 - 4356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Verburg, I. B. Renes, H. P. Meijer, J. A. J. M. Taminiau, H. A. Buller, A. W. C. Einerhand, and J. Dekker Selective sparing of goblet cells and Paneth cells in the intestine of methotrexate-treated rats Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1037 - G1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Esworthy, J. R. Mann, M. Sam, and F.-F. Chu Low glutathione peroxidase activity in Gpx1 knockout mice protects jejunum crypts from gamma -irradiation damage Am J Physiol Gastrointest Liver Physiol, August 1, 2000; 279(2): G426 - G436. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Panoskaltsis-Mortari, D. H. Ingbar, P. Jung, I. Y. Haddad, P. B. Bitterman, O. D. Wangensteen, C. L. Farrell, D. L. Lacey, and B. R. Blazar KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L988 - L999. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Hill and J. L. M. Ferrara The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood, May 1, 2000; 95(9): 2754 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P W Finch and A L Cheng Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease Gut, December 1, 1999; 45(6): 848 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. I. Krijanovski, G. R. Hill, K. R. Cooke, T. Teshima, J. M. Crawford, Y. S. Brinson, and J. L.M. Ferrara Keratinocyte Growth Factor Separates Graft-Versus-Leukemia Effects From Graft-Versus-Host Disease Blood, July 15, 1999; 94(2): 825 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Miceli, M. Hubert, G. Santiago, D.-L. Yao, T. A. Coleman, K. A. Huddleston, and K. Connolly Efficacy of Keratinocyte Growth Factor-2 in Dextran Sulfate Sodium-Induced Murine Colitis J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 464 - 471. [Abstract] [Full Text] |
||||
![]() |
C. R. Jonas, C. F. Estívariz, D. P. Jones, L. H. Gu, T. M. Wallace, E. E. Diaz, R. R. Pascal, G. A. Cotsonis, and T. R. Ziegler Keratinocyte Growth Factor Enhances Glutathione Redox State in Rat Intestinal Mucosa during Nutritional Repletion J. Nutr., July 1, 1999; 129(7): 1278 - 1284. [Abstract] [Full Text] |
||||
![]() |
P Gillis, U Savla, O. Volpert, B Jimenez, C. Waters, R. Panos, and N. Bouck Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function J. Cell Sci., January 6, 1999; 112(12): 2049 - 2057. [Abstract] [PDF] |
||||
![]() |
D. M. Danilenko Preclinical and Early Clinical Development of Keratinocyte Growth Factor, an Epithelial- Specific Tissue Growth Factor Toxicol Pathol, January 1, 1999; 27(1): 64 - 71. [Abstract] [PDF] |
||||
![]() |
A. Panoskaltsis-Mortari, D. L. Lacey, D. A. Vallera, and B. R. Blazar Keratinocyte Growth Factor Administered Before Conditioning Ameliorates Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice Blood, November 15, 1998; 92(10): 3960 - 3967. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, E. S. Yi, A. M. Havill, I. Sarosi, L. Whitcomb, S. Yin, S. C. Middleton, P. Piguet, and T. R. Ulich Intravenous keratinocyte growth factor protects against experimental pulmonary injury Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L800 - L805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Estivariz, C. R. Jonas, L. H. Gu, E. E. Diaz, T. M. Wallace, R. R. Pascal, C. L. Farrell, and T. R. Ziegler Gut-Trophic Effects of Keratinocyte Growth Factor in Rat Small Intestine and Colon During Enteral Refeeding JPEN J Parenter Enteral Nutr, September 1, 1998; 22(5): 259 - 267. [Abstract] [PDF] |
||||
![]() |
M. Bjerknes and H. Cheng Modulation of specific intestinal epithelial progenitors by enteric neurons PNAS, October 23, 2001; 98(22): 12497 - 12502. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Huang, C. J. Kemp, J. L. Williams, C. R. Erwin, and B. W. Warner Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G432 - G442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |